SymBio Competitors

SYMQY Stock  USD 0.56  0.00  0.00%   
Analyzing SymBio Pharmaceuticals competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of SymBio Pharmaceuticals to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out SymBio Pharmaceuticals Correlation with its peers.

SymBio Pharmaceuticals vs Priority Aviation Correlation

Moving against SymBio Pink Sheet

  0.86TAK Takeda PharmaceuticalPairCorr
  0.86HLN Haleon plcPairCorr
  0.85TKPHF Takeda PharmaceuticalPairCorr
  0.81HLNCF Haleon plcPairCorr
  0.72GAM General American InvPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.030.562.13
Details
Intrinsic
Valuation
LowRealHigh
0.020.492.06
Details
Naive
Forecast
LowNextHigh
0.010.592.16
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.560.560.56
Details

SymBio Pharmaceuticals Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between SymBio Pharmaceuticals and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of SymBio and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of SymBio Pharmaceuticals does not affect the price movement of the other competitor.

High positive correlations

BNKLBGMD
PJETBGMD
PJETBNKL
CFRXQLITH
LITHBGMD
CFRXQBGMD
  

High negative correlations

PJETCFRXQ
BNKLCFRXQ
PJETLITH
BNKLLITH
CFRXQBGMD
LITHBGMD

Risk-Adjusted Indicators

There is a big difference between SymBio Pink Sheet performing well and SymBio Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SymBio Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

SymBio Pharmaceuticals Competitive Analysis

The better you understand SymBio Pharmaceuticals competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, SymBio Pharmaceuticals' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across SymBio Pharmaceuticals' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SYMQY BGMD LITH BNKL PJET
 0.00 
 0.56 
SymBio
 0.00 
 0.0001 
BGMD
 0.00 
 0.0001 
LITH
 0.00 
 0.0001 
Bionik
 0.00 
 0.0001 
Priority
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Number Of Shares Shorted
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Rate Of Daily Change
Day Median Price
Day Typical Price
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio

SymBio Pharmaceuticals Competition Performance Charts

Five steps to successful analysis of SymBio Pharmaceuticals Competition

SymBio Pharmaceuticals' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by SymBio Pharmaceuticals in relation to its competition. SymBio Pharmaceuticals' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of SymBio Pharmaceuticals in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact SymBio Pharmaceuticals' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to SymBio Pharmaceuticals, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your SymBio Pharmaceuticals position

In addition to having SymBio Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Railroads Thematic Idea Now

Railroads
Railroads Theme
Companies involved in manufacturing and maintenance of freight railroads and passenger trains as well as providing railroad services to public. The Railroads theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Railroads Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for SymBio Pink Sheet Analysis

When running SymBio Pharmaceuticals' price analysis, check to measure SymBio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SymBio Pharmaceuticals is operating at the current time. Most of SymBio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of SymBio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SymBio Pharmaceuticals' price. Additionally, you may evaluate how the addition of SymBio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.